CellSeed Inc. (TYO:7776)

CellSeed Revenue

In the year 2021, CellSeed had annual revenue of 161.00M JPY, down -19.10%. CellSeed had revenue of 33.00M in the quarter ending December 31, 2021, a decrease of -71.55%. That makes CellSeed the 43,585th largest company in the world by revenue and 3,861st in Japan.

• Revenue: 161.00M
• Revenue Growth: -19.10%
• P/S Ratio: 46.58
• Revenue / Employee: 3.66M
• Employees: 44
• Market Cap: 7.50B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Regenerative Medicine Support Business 147.82M 91.4%
• Cell Sheet Regenerative Medicine 13.85M 8.6%

By Geography

Chart

• Japan 87.19M 53.9%
• Europe 56.59M 35.0%
• Asia 17.90M 11.1%

Fiscal year ended Dec 31, 2021

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2021	161.00M	-38.00M	-19.10%
Dec 31, 2020	199.00M	-76.00M	-27.64%
Dec 31, 2019	275.00M	-751.00M	-73.20%
Dec 31, 2018	1.03B	941.00M	1,107.06%
Dec 31, 2017	85.00M	-15.00M	-15.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 28, 2022

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error